Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Tallman

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Cancer|February 19, 1999
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot studyM S Tallman, S Lee, B I Sikic, et al.
Blood|November 1, 1992
A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemiaM S Tallman, D Hakimian, D Variakojis, et al.
Blood|February 1, 1996
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphomaT M Kuzel, A Hurria, E Samuelson, et al.
American Journal of Clinical Pathology|April 1, 1996
Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemiaW G Finn, M Thangavelu, K K Yelavarthi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphomaM Hoffman, M S Tallman, D Hakimian, et al.
Blood|July 1, 1997
RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative studyY P Li, J Andersen, A Zelent, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
Leukemia & Lymphoma|June 1, 1997
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disordersL R Kong, E Samuelson, S T Rosen, et al.
Cancer Research|December 29, 1998
Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cellsD C Zhou, S J Hallam, S J Lee, et al.
American Journal of Clinical Pathology|August 1, 1991
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disordersC R Schad, W J Kraker, S M Jalal, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Cancer|February 19, 1999
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot studyM S Tallman, S Lee, B I Sikic, et al.
Blood|November 1, 1992
A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemiaM S Tallman, D Hakimian, D Variakojis, et al.
Blood|February 1, 1996
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphomaT M Kuzel, A Hurria, E Samuelson, et al.
American Journal of Clinical Pathology|April 1, 1996
Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemiaW G Finn, M Thangavelu, K K Yelavarthi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphomaM Hoffman, M S Tallman, D Hakimian, et al.
Blood|July 1, 1997
RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative studyY P Li, J Andersen, A Zelent, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
Leukemia & Lymphoma|June 1, 1997
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disordersL R Kong, E Samuelson, S T Rosen, et al.
Cancer Research|December 29, 1998
Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cellsD C Zhou, S J Hallam, S J Lee, et al.
American Journal of Clinical Pathology|August 1, 1991
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disordersC R Schad, W J Kraker, S M Jalal, et al.
Pageof 10